Showing 1 - 6 results of 6 for search 'Swati Garg', query time: 0.01s Refine Results
  1. 1
    Academic writing in the age of AI: Comparing the reliability of ChatGPT and Bard with Scopus and Web of Science

    Academic writing in the age of AI: Comparing the reliability of ChatGPT and Bard with Scopus and Web of Science by Swati Garg, Asad Ahmad, Dag Øivind Madsen

    Published 2024-10-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Unraveling medication errors in Indian scholarly articles (2010–2023): A comprehensive review

    Unraveling medication errors in Indian scholarly articles (2010–2023): A comprehensive review by J. Shanmugapriya, Seema Mehta, Swati Garg, Tanjul Saxena, Neeti Sharma, Geetika Goswami

    Published 2024-12-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    CRISPR/Cas9-engineering of Kell null erythrocytes to unveil host targeted irresistible antimalarial

    CRISPR/Cas9-engineering of Kell null erythrocytes to unveil host targeted irresistible antimalarial by Geeta Kumari, Pragya Gupta, Sangam G. Goswami, Ravi Jain, Sakshi Anand, Shreeja Biswas, Swati Garg, Priya Thakur, Vinodh Saravanakumar, V. R. Arvinden, Bidhan Goswami, Ipsita Pal Bhowmick, Narla Mohandas, Jeremy Burrows, Sivaprakash Ramalingam, Shailja Singh

    Published 2025-05-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Dual CARM1-and IKZF3-targeting: A novel approach to multiple myeloma therapy

    Dual CARM1-and IKZF3-targeting: A novel approach to multiple myeloma therapy by Wei Ni, Swati Garg, Basudev Chowdhury, Martin Sattler, Dana Sanchez, Chengcheng Meng, Taisei Akatsu, Katherine A. Donovan, Jun Qi, Michelle Y. Wang, Cara Ann Starnbach, Xiaoxi Liu, Maria Tarazona Guzman, Wei Pin Teh, Richard Stone, James D. Griffin, Sara Buhrlage, Ellen Weisberg

    Published 2025-06-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Dual CARM1-and IKZF3-targeting: A novel approach to multiple myeloma therapy synergy between CARM1 inhibition and IMiDs

    Dual CARM1-and IKZF3-targeting: A novel approach to multiple myeloma therapy synergy between CARM1 inhibition and IMiDs by Wei Ni, Swati Garg, Basudev Chowdhury, Martin Sattler, Dana Sanchez, Chengcheng Meng, Taisei Akatsu, Katherine A. Donovan, Jun Qi, Michelle Y. Wang, Cara Ann Starnbach, Xiaoxi Liu, Maria Tarazona Guzman, Wei Pin Teh, Richard Stone, James D. Griffin, Sara Buhrlage, Ellen Weisberg

    Published 2025-03-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    CDK7/12/13 inhibition targets an oscillating leukemia stem cell network and synergizes with venetoclax in acute myeloid leukemia

    CDK7/12/13 inhibition targets an oscillating leukemia stem cell network and synergizes with venetoclax in acute myeloid leukemia by Lixiazi He, Christian Arnold, Judith Thoma, Christian Rohde, Maksim Kholmatov, Swati Garg, Cheng‐Chih Hsiao, Linda Viol, Kaiqing Zhang, Rui Sun, Christina Schmidt, Maike Janssen, Tara MacRae, Karin Huber, Christian Thiede, Josée Hébert, Guy Sauvageau, Julia Spratte, Herbert Fluhr, Gabriela Aust, Carsten Müller‐Tidow, Christof Niehrs, Gislene Pereira, Jörg Hamann, Motomu Tanaka, Judith B Zaugg, Caroline Pabst

    Published 2022-03-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: